Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 07-04-2015 | Practice Area: | Equity Capital Markets |
| Deal Title: | Coherus BioSciences Offering of NASDAQ Common Stock | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised the joint book-running managers in connection with the USD120 million Coherus BioSciences, Inc. public offering. Coherus's common stock is listed on the NASDAQ Global Market under the symbol CHRS.
Based in Redwood City, California, Coherus is a late-stage biologics platform company focused on the global biosimilar market.
The Davis Polk corporate team included partner Alan F. Denenberg and associates Stephen Salmon and Max Brunner.
|
||
| Financial Center: | Silicon Valley | Value: | 100.01-500.00 |
| Advised Party: | Lead Manager | Law Firm | Davis Polk |
| Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States |
| Classification: |
Secondary Offerings and Placings NASDAQ: |
Lawyer | Alan F Denenberg |
